Healthcare -
Biotechnology - NASDAQ - US
$ 0.105
-1.73 %
$ 6.92 M
Market Cap
-0.07
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Lyra Therapeutics, Inc.
| Revenue | 1.53 M |
| Cost Of Revenue | 471 K |
| Gross Profit | 1.06 M |
| Operating Expenses | 97.9 M |
| Operating Income | -96.3 M |
| Other Expenses | -2.91 M |
| Net Income | -93.4 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 1.5 | 1.6 | 1.4 | 0.3 | 0 | 0 | 1.2 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.5 | 0 | 1.1 | 1.0 | 95 K | 27 K | 0 |
| Gross Profit | 1.1 | 1.6 | 0.3 | (0.7) | 95 K | 27 K | 1.2 |
| OPERATING INCOME | |||||||
| Operating Expenses | 97.9 | 68.7 | 56.4 | 43.9 | 22.2 | 16.5 | 8.5 |
| Selling, General and Administrative Expenses | 18.5 | 19.1 | 17.6 | 14.2 | 9.7 | 4.5 | 3.5 |
| Research and Development Expenses | 43.8 | 48.0 | 38.8 | 29.7 | 12.5 | 12.0 | 5.0 |
| Operating Income | (96.3) | (67.1) | (56.3) | (43.6) | (22.2) | (16.5) | (7.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 |
| Total Other Income | 3.0 | 4.5 | 1.0 | 0.1 | 82 K | 0.2 | 1.2 |
| Pre-Tax Income | (93.4) | (62.6) | (55.3) | (43.5) | (22.1) | (16.3) | (6.0) |
| NET INCOME | |||||||
| Tax Provision | 39 K | 59 K | 13 K | (1.1) | 82 K | (0.2) | (1.2) |
| Net Income | (93.4) | (62.7) | (55.3) | (42.4) | (22.0) | (16.1) | (6.0) |
| EPS | 1.43 | 1.26 | 1.83 | 3.27 | 2.57 | 1.25 | 0.96 |